MEGHAN MCGRATH: Open Payments
NPI 1326753807 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 63 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $181 · 2025 $1,119
Food & beverage: $1,119
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $146 |
| PFIZER INC. | 9 | $126 |
| Celltrion USA Inc. | 1 | $61 |
| ABBVIE INC. | 3 | $56 |
| Daiichi Sankyo Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Aveo Pharmaceuticals, Inc. | 3 | $46 |
| GENZYME CORPORATION | 2 | $40 |
| Incyte Corporation | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: KEYTRUDA, VEGZELMA, AYVAKIT, FOTIVDA, XTANDI, JAKAFI, OPDIVO, EPKINLY.
Industry payments across MT — which companies pay providers there.
